Purdue University researchers are helping to develop physIQ software that could indicate that a person should get tested for COVID-19 by detecting specific changes in heart and breathing rates while the person wears a smartwatch.

In the Internet of Medical Things (IoMT), medical devices connect wirelessly over the internet to personal computing devices and larger-scale health care IT systems, enabling remote personal monitoring of patients. Purdue IE’s Ramses Martinez is developing epidermal, wearable sensors to help do this more inexpensively.

Purdue BME's Matthew P. Ward uses AI algorithms to identify a relationship between stimulation, nerve response, and a change in patient perception of symptoms - to provide personalized medicine and improve healthcare.

Purdue BME’s Taeyoon Kim developed a model to investigate the actin cytoskeleton, a cell structure that plays a crucial role in a wide range of cellular functions.

Soft robots are built with compliant materials, such as those that give organisms in the wild the flexibility to navigate and adapt to their environments — compliance meaning the ability to yield elastically and deform shape in response to an impediment or force.

Combining 4D and 3D technologies can help healthcare providers better predict, diagnose and treat heart disease. Purdue BME's Craig Goergen describes the need and his team’s novel solution.

Purdue Weldon School of Biomedical Engineering researchers developed an airborne disinfection method – using edible food-coloring dyes – to apply to the entire body and rooms for sterilization and lowering the risk of infection.

Doug Brubaker, a Purdue assistant professor of biomedical engineering, uses computational and experimental approaches to study host-microbiome interactions in cancers and inflammatory diseases.

A Purdue Engineering team developed a fully implantable transmitter chip for wireless sensor nodes and biomedical devices. It's smaller and uses less energy than other current designs.

The Purdue team, including Dr. Riyi Shi and innovators from several disciplines across the university, received a $1.3 million grant from the Department of Defense for their work developing biomarkers and identifying new targets for phagocytic function of microglial cells, immune cells in the brain, in the context of brain injury-related Alzheimer’s disease and other dementia.